Pharmarise Holdings Corporation (TYO:2796)

Pharmarise Holdings Revenue

In the fiscal year ending May 31, 2026, Pharmarise Holdings had annual revenue of 69.51B JPY with 9.45% growth. Pharmarise Holdings had revenue of 18.96B in the quarter ending May 31, 2026, with 11.97% growth.

• Revenue: 69.51B
• Revenue Growth: +9.45%
• P/S Ratio: 0.08
• Revenue / Employee: 34.09M
• Employees: 2,039
• Market Cap: 5.57B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2026	69.51B	6.00B	9.45%
May 31, 2025	63.51B	9.04B	16.60%
May 31, 2024	54.47B	2.44B	4.68%
May 31, 2023	52.03B	422.00M	0.82%
May 31, 2022	51.61B	-716.00M	-1.37%

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2026

Data Sources Report a data error